Venture capital deals in China suffered a steep 44.21 per cent decline in transaction value in February 2020 largely on account of the impact of the novel coronavirus outbreak that has thrown business activity out of gear and far fewer big-ticket funding rounds. The first coronavirus case was reported in China’s Wuhan province on December 31, 2019.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
